Current Projects

International grants:

Exploring the molecular determinants and functional role of T-type channel dimerization (2018 –2020)
Principal Investigator: Ľubica Lacinová

Slovak Research and Development Agency (SRDA):

Coordinated at IMPG SAS

sparks APVV-15-0388
Prenatal and postnatal effects of ? and µ opioid receptor ligands on the hippocampal development and function (2016 – 2020)
Principal Investigator: Ľubica Lacinová
PGP APVV-14-0334
Possible dual function of P-glycoprotein in leukemia cells: efflux pump and regulatory protein (2015-2018)
Principal Investigator: Zdena Sulová

Collaborative projects

APVV-16-0439
The application of myrosinase for sulforaphane activation in development of a novel product exhibiting cancer prevention effects (2017-2021)
Principal Investigator (IMPG SAS): Zdena Sulová
APVV-15-0641
Smart MoS2 platform for cancer diagnosis and targeted treatment (2016-2020)
Principal Investigator (IP SAS): Peter Šiffalovič
Team leader at IMPG SAS: Albert Breier
APVV-15-0372
Novel synergistic antitumour properties of nuclear retinoid X receptor (RXR) agonists as a consequence of the conditional RXR-RAR heterodimer formation in human breast cancer cells (2016-2020)
Principal Investigator (IEE BMC SAS): Július Brtko
Team leader at IMPG SAS: Zdena Sulová
PGP APVV-15-0303
Defense mechanisms of neoplastic cells against chemical stress (2016-2020)
Principal Investigator(FCHFT STU): Albert Breier
Team leader at IMPG SAS: Zdena Sulová
APVV-14-0753
Biochips and biosensors for glycorecognition, their development, preparation and application in cancer research (2015-2019)
Principal Investigator (ICH SAS): Jaroslav Katrlík
Team leader at IMPG SAS: Zdena Sulová

Scientific Grant Agency of MESRaS and SAS (VEGA):

VEGA 2/0090/18
Vzťah mikroarchitektúry mitochondriálnej siete a jej funkčného spriahnutia v kardiomyocytoch (2018 – 2021)
Principal Investigator: Zuzana Tomášková
image VEGA 2/0057/18
Analyses of allele-specific regulation of CD33 expression (2018 – 2021)
Principal Investigator: Jana Královičová
VEGA 2/0157/18
The effect of polyphenols on the functions of signal proteins involved in proteins N-glycosylation in the endoplasmic reticulum of leukemia cells, depending on the expression of P-glycoprotein (2018-2021)
Principal Investigator: Viera Boháčová
PGP VEGA 2/0122/17
Study of changes in expression of some regulatory and functional proteins connected with the presence of P-gp protein in leukemic cells (2017-2020)
Principal Investigator: Zdena Sulová
image VEGA 2/0086/17
Luminal regulation of the cardiac ryanodine receptor and its molecular mechanisms (2017 – 2019)
Principal Investigator: Marta Gaburjáková
PGP VEGA 2/0156/16
The effect of endoplasmic reticulum stress inductors and proteaosome inhibitors on leukemia cell line L1210, SKM-1 and MOLM-13 with induced P-glycoprotein overexpression (2016-2018)
Principal Investigator: Mário Šereš
VEGA_0107_0019_DAAD VEGA 2/0107/16
Novel pathways of N-type (CaV2.2) calcium channels regulation (2016 – 2018)
Principal Investigator: Ľubica Lacinová
PGP VEGA 2/0028/15
Changes of leukemia cells drug sensitivity induced by changes of membrane drug transporters expression profile (2015-2018)
Principal Investigator: Albert Breier
image VEGA 2/0046/18
Investigation of the mechanism of action of novel putative antidepressant drugs: pyridoindole derivatives and trace amine-associated receptor-1 (TAAR1) ligands (2018 – 2021)
Principal Investigator: Eliyahu Dremencov
BLM VEGA 2/0011/18
Regulation of the cardiac ryanodine receptor phosphorylated by protein kinase A (2018 – 2020)
Principal Investigator: Jana Gaburjáková

Other national projects:

firing SAS Stipend
Role of neurosecretory neurons and calcium signalling in depression and addictive behaviour: Assessment by in-vivo electrophysiology (2013 – 2017)
Principal Investigator: Eliyahu Dremencov